Balancing Reform and Growth: China’s 13th Five-Year Plan
At the recent Fifth Plenum China’s leadership rolled out its proposal for the 13th Five-Year Plan
At the recent Fifth Plenum China’s leadership rolled out its proposal for the 13th Five-Year Plan
While foreign investment in some sectors of China’s healthcare market has been recently liberalised others remain restricted, and risky.
China is one of the world’s most attractive healthcare markets, and is by far the fastest growing emerging market.
The shift from government-fixed prices to free-market tendering
Digitalisation is rapidly transforming China’s healthcare industry.
Interview with Dr Pan Huaiyu, General Manager, Siemens Shenzhen Magnetic Resonance Ltd
China presents a challenging environment for foreign manufacturing companies.
China’s fast-growing medical device market presents numerous opportunities for European companies.
From an ancient Chinese recipe to industrial production in Europe
Recent Comments